CBD Global Sciences Inc. (CBDNF)
CBD Global Sciences Inc. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Lakewood, CO, US. The stock last traded at $0.04, down 2.67% on the session, giving a market capitalisation of $2.1M. On trailing twelve-month figures it carries a trailing P/E of -0.28, a net margin of -3146.3%. Its beta of 0.43 implies it has historically moved less than the broad market.
CBD Global Sciences Inc. operates within the cannabidiol (CBD) sector, handling the cultivation, processing, and manufacturing of CBD products. Its offerings include biomass, various CBD oils, and other CBD-based items, which are marketed under the Aethics, CannaOil, and Strasburg Pharms brands. Founded in 2018, the company's main offices are located in Lakewood, Colorado.
CBD Global Sciences Inc. is most often compared with the following Healthcare names: